A 26-year-old man has been ordered to stand trial in connection with an alleged drunken driving crash that killed two people. A Superior Court judge on Friday found sufficient evidence for the case ...

Manfredo Martin-Michael Madrigal, 38, also faced charges stemming from alleged harassment against two former girlfriends who were potential witnesses in the case. In court documents, one woman ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came after the drugmaker announced its preliminary fourth-quarter and full ...

This cold case is close to her heart because the victim happens to be her estranged half sister, Ana Madrigal. Together with her TV crew, Christine attempts to uncover the truth behind what really ...

Madrigal Pharmaceuticals announced its preliminary Q4 and full-year results. The company topped the official Wall Street estimates, but seems to have missed the so-called "whisper numbers ...

Looking to add to their infield depth, the New York Mets agreed to a one-year deal with veteran Nick Madrigal on Friday, league sources confirmed. The New York Post first reported the agreement.

CONSHOHOCKEN, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction ...

When the New York Mets signed former Chicago Cubs infielder Nick Madrigal at the end of January, many assumed this meant that there was no longer any chance Jos ...

Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target of $427.00. Discover outperforming stocks and invest ...

Madrigal Pharmaceuticals (MDGL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Liisa ...